Cerebral Glioblastoma: A Review on Genetic Alterations, Signaling Pathways, and Clinical Managements
Open Access
- 20 October 2021
- journal article
- review article
- Published by Briefland in Jentashapir Journal of Cellular and Molecular Biology
- Vol. 12 (4)
- https://doi.org/10.5812/jjcmb.119223
Abstract
Context: Glioblastoma, previously known as glioblastoma multiforme (GBM), is a grade IV astrocytoma that frequently affects patients with a mean age of 45 and above. It is generally categorized into primary and secondary subtypes, based on research conducted by Hans Joachim Scherer. Evidence Acquisition: This review concentrates on cellular and genetic drawbacks that can lead to the appearance of glioblastoma. National Center for Biotechnology Information (NCBI) was the main source used for writing this review article, followed by Google scholar. The following keywords were used to retrieve articles: 'glioblastoma', 'brain tumors', 'glioma', 'LOH', and 'cellular and signaling pathways in glioblastoma'. Results: Several genetic alterations and cellular pathways are involved in the appearance and progression of glioblastoma, including loss of heterozygosity (LoH), TP53 mutation, isocitrate dehydrogenase 1 (IDH1) mutation, P16INK4/RB1 pathway, and EGFR/PTEN/Akt/mTOR pathway. The majority (70%) of primary glioblastomas are caused by (LoH), and it mostly occurs in older people. Secondary glioblastoma is mainly manifested by TP53 mutation and usually affects younger people. Understanding the alterations and cellular mechanisms involved in glioblastoma is important to develope new therapeutic regimes. Surgery, radiation therapy, temozolomide, and TTFields are the four most important therapeutic options available for treating patients. Conclusions: In this review, the genetic alterations and cellular pathways which could lead to the appearance of this tumor were highlighted, and the latest options for treating patients dealing with glioblastoma were discussed.Keywords
This publication has 25 references indexed in Scilit:
- Emerging targets for glioblastoma stem cell therapyJournal of Biomedical Research, 2016
- GliomaNature Reviews Disease Primers, 2015
- PTEN function: the long and the short of itTrends in Biochemical Sciences, 2014
- Glioblastoma and Other Malignant GliomasJAMA, 2013
- RB1 in cancer: Different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesisJournal of Cellular Physiology, 2013
- Genetic Alterations in GliomaCancers, 2011
- Genetic alterations and signaling pathways in the evolution of gliomasCancer Science, 2009
- Cerebellar glioblastomas: pathophysiology, clinical presentation and managementActa Neurochirurgica, 2009
- PTEN and the PI3-Kinase Pathway in CancerAnnual review of pathology, 2009
- Genetic Pathways to Primary and Secondary GlioblastomaThe American Journal of Pathology, 2007